These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26687647)

  • 1. Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.
    Zhong X; Zhao E; Tang C; Zhang W; Tan J; Dong Z; Ding HF; Cui H
    Tumour Biol; 2016 Jun; 37(6):7615-23. PubMed ID: 26687647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic drug tigecycline inhibited cell proliferation and induced autophagy in gastric cancer cells.
    Tang C; Yang L; Jiang X; Xu C; Wang M; Wang Q; Zhou Z; Xiang Z; Cui H
    Biochem Biophys Res Commun; 2014 Mar; 446(1):105-12. PubMed ID: 24582751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline Inhibits Glioma Growth by Regulating miRNA-199b-5p-HES1-AKT Pathway.
    Yang R; Yi L; Dong Z; Ouyang Q; Zhou J; Pang Y; Wu Y; Xu L; Cui H
    Mol Cancer Ther; 2016 Mar; 15(3):421-9. PubMed ID: 26823491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
    Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
    Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.
    Hu H; Dong Z; Tan P; Zhang Y; Liu L; Yang L; Liu Y; Cui H
    Oncotarget; 2016 Jan; 7(3):3171-85. PubMed ID: 26621850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
    Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G
    Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells.
    Meyer GE; Chesler L; Liu D; Gable K; Maddux BA; Goldenberg DD; Youngren JF; Goldfine ID; Weiss WA; Matthay KK; Rosenthal SM
    J Cell Biochem; 2007 Dec; 102(6):1529-41. PubMed ID: 17486636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of neuroblastoma cell lines in insulin-like growth factor 1 receptor/Akt pathway-mediated cell proliferative responses.
    Qi L; Toyoda H; Shankar V; Sakurai N; Amano K; Kihira K; Iwasa T; Deguchi T; Hori H; Azuma E; Gabazza EC; Komada Y
    Cancer Sci; 2013 Sep; 104(9):1162-71. PubMed ID: 23710710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant flavonoid taxifolin inhibits the growth, migration and invasion of human osteosarcoma cells.
    Chen X; Gu N; Xue C; Li BR
    Mol Med Rep; 2018 Feb; 17(2):3239-3245. PubMed ID: 29257319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline exerts an antitumoral effect in oral squamous cell carcinoma.
    Ren A; Qiu Y; Cui H; Fu G
    Oral Dis; 2015 Jul; 21(5):558-64. PubMed ID: 25581076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting PI3K in neuroblastoma.
    Spitzenberg V; König C; Ulm S; Marone R; Röpke L; Müller JP; Grün M; Bauer R; Rubio I; Wymann MP; Voigt A; Wetzker R
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1881-90. PubMed ID: 20224967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Marine Alkaloid, Ascomylactam A, Suppresses Lung Tumorigenesis via Inducing Cell Cycle G1/S Arrest through ROS/Akt/Rb Pathway.
    Wang L; Huang Y; Huang CH; Yu JC; Zheng YC; Chen Y; She ZG; Yuan J
    Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 32992455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
    Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.
    Zheng YT; Yang HY; Li T; Zhao B; Shao TF; Xiang XQ; Cai WM
    Acta Pharmacol Sin; 2015 May; 36(5):614-26. PubMed ID: 25864651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition.
    Li W; Xie Y; Sun RW; Liu Q; Young J; Yu WY; Che CM; Tam PK; Ren Y
    Br J Cancer; 2009 Jul; 101(2):342-9. PubMed ID: 19550420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):14-20. PubMed ID: 26427870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel derivative of quinazoline, WYK431 induces G2/M phase arrest and apoptosis in human gastric cancer BGC823 cells through the PI3K/Akt pathway.
    Wang TE; Wang YK; Jin J; Xu BL; Chen XG
    Int J Oncol; 2014 Aug; 45(2):771-81. PubMed ID: 24859921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of autophagy enhances the antitumour activity of tigecycline in multiple myeloma.
    Ma R; Zhang Y; Wang W; Wu J; Yang Q; Xu W; Jiang S; Han Y; Yu K; Zhang S
    J Cell Mol Med; 2018 Dec; 22(12):5955-5963. PubMed ID: 30247801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.